基于机器学习的药物-靶标相互作用预测*

近年来,随着计算机硬件、软件工具和数据丰度的不断突破,以机器学习为代表的人工智能技术在生物、基础医学和药学等领域的应用不断拓展和融合,极大地推动了这些领域的发展,尤其是药物研发领域的变革。其中,药物-靶标相互作用(drug-target interactions, DTI)的识别是药物研发领域中的重要难题和人工智能技术交叉融合的热门方向,研究人员在DTI预测方面做了大量的工作,构建了许多重要的数据库,开发或拓展了各类机器学习算法和工具软件。对基于机器学习的DTI预测的基本流程进行了介绍,并对利用机器学习预测DTI的研究进行了回顾,同时对不同的机器学习方法运用于DTI预测的优缺点进行了简单总结,以期对开发更加有效的预测算法和DTI预测的发展提供帮助。     

机器学习方法在基因功能注释中的应用

目前,基于计算机数学方法对基因的功能注释已成为热点及挑战,其中以机器学习方法应用最为广泛。生物信息学家不断提出有效、快速、准确的机器学习方法用于基因功能的注释,极大促进了生物医学的发展。本文就关于机器学习方法在基因功能注释的应用与进展作一综述。主要介绍几种常用的方法,包括支持向量机、k近邻算法、决策树、随机森林、神经网络、马尔科夫随机场、logistic回归、聚类算法和贝叶斯分类器,并对目前机器学习方法应用于基因功能注释时如何选择数据源、如何改进算法以及如何提高预测性能上进行讨论。     

利用人工智能预测癌症的易感性、复发性和生存期

癌症具有较高的发病率和致死率,对人类健康具有重大威胁。癌症预后分析可以有效避免过度治疗及医疗资源的浪费,为医务人员及家属进行医疗决策提供科学依据,已成为癌症研究的必要条件。随着近年来人工智能技术的迅速发展,对癌症患者的预后情况进行自动化分析成为可能。此外,随着医疗信息化的发展,智慧医疗的理念受到广泛关注。癌症患者作为智慧医疗的重要组成部分,对其进行有效的智能预后分析十分必要。本文综述现有基于机器学习的癌症预后方法。首先,对机器学习与癌症预后进行概述,介绍癌症预后及相关的机器学习方法,分析机器学习在癌症预后中的应用;然后,对基于机器学习的癌症预后方法进行归纳,包括癌症易感性预测、癌症复发性预测、癌症生存期预测,梳理了它们的研究现状、涉及到的癌症类型与数据集、用到的机器学习方法及预后性能、特点、优势与不足;最后,对癌症预后方法进行总结与展望。     

机器学习在肠道菌群宿主表型预测中的应用

随着第二代DNA测序技术的发展,研究人员积累了大量的肠道菌群数据,研究表明肠道菌群与宿主健康状况存在密切联系,因此如何对复杂、高维的肠道菌群数据进行建模分析,是当前生物信息学研究中的重要挑战。人工智能的兴起为处理肠道菌群数据,揭示肠道菌群与宿主表型之间的复杂关系提供了可能。综述了现阶段肠道菌群与宿主表型之间的相关研究,重点介绍了常用的5种机器学习算法（线性回归、支持向量机、K-近邻、随机森林、人工神经网络）的理论原理及在相关研究中的应用,对预测宿主表型的机器学习算法选择提出了建议,并对该领域的未来发展进行了展望,以期为利用机器学习对肠道菌群宿主表型预测提供参考依据。     

基于机器学习的肠道菌群数据建模与分析研究综述

人体肠道菌群与人类的健康和疾病存在密切关系,对肠道菌群的宏基因组数据进行建模和分析,在疾病预测及诊断相关领域科学研究和社会应用方面均具有重要意义。本文从大数据分析和机器学习的角度,对人体肠道菌群数据的建模、分析和预测算法的原理、过程以及典型研究应用实例进行综述,以期推动肠道菌群分析相关研究发展以及探索结合机器学习算法进行肠道菌群分析的有效方式,同时也为开发基于肠道菌群数据的新型诊疗手段提供借鉴,推动我国精准医疗事业发展。     

机器学习在微生物组宿主表型预测中的应用

随着大数据时代的到来,如何将生物组学海量数据转化为易理解及可视化的知识是当前生物信息学面临的重要挑战之一。为了处理复杂、高维的微生物组数据,目前机器学习算法已被应用于人体微生物组研究,以揭示疾病背后的复杂机制。本文首先简述了微生物组数据处理方法及常用的机器学习算法,如支持向量机(SVM)、随机森林(RF)和人工神经网络(ANN)等,然后对机器学习的工作流程及其要点进行阐述,并探讨了机器学习算法在基于微生物组数据预测宿主表型方面的应用。最后以唾液微生物组数据预测口腔异味为例,实现了机器学习算法的模型构建与评估分析,并提供了可用于微生物组研究实践的R/Python代码(https://github.com/LiLabZSU/microbioML)。     

环境微生物研究中机器学习算法及应用

微生物在环境中无处不在，它们不仅是生物地球化学循环和环境演化的关键参与者，也在环境监测、生态治理和保护中发挥着重要作用。随着高通量技术的发展，大量微生物数据产生，运用机器学习对环境微生物大数据进行建模和分析，在微生物标志物识别、污染物预测和环境质量预测等领域的科学研究和社会应用方面均具有重要意义。机器学习可分为监督学习和无监督学习2大类。在微生物组学研究当中，无监督学习通过聚类、降维等方法高效地学习输入数据的特征，进而对微生物数据进行整合和归类。监督学习运用有特征和标记的微生物数据集训练模型，在面对只有特征没有标记的数据时可以判断出标记，从而实现对新数据的分类、识别和预测。然而，复杂的机器学习算法通常以牺牲可解释性为代价来重点关注模型预测的准确性。机器学习模型通常可以看作预测特定结果的“黑匣子”，即对模型如何得出预测所知甚少。为了将机器学习更多地运用于微生物组学研究、提高我们提取有价值的微生物信息的能力，深入了解机器学习算法、提高模型的可解释性尤为重要。本文主要介绍在环境微生物领域常用的机器学习算法和基于微生物组数据的机器学习模型的构建步骤，包括特征选择、算法选择、模型构建和评估等，并对各种机器学习模型在环境微生物领域的应用进行综述，深入探究微生物组与周围环境之间的关联，探讨提高模型可解释性的方法，并为未来环境监测、环境健康预测提供科学参考。     

基于质谱的蛋白质生物标志物发现中的特征选择与机器学习方法研究进展

随着质谱技术的进步以及生物信息学与统计学算法的发展,以疾病研究为主要目的之一的人类蛋白质组计划正快速推进。蛋白质生物标志物在疾病早期诊断和临床治疗等方面有着非常重要的意义,其发现策略和方法的研究已成为一个重要的热点领域。特征选择与机器学习对于解决蛋白质组数据"高维度"及"稀疏性"问题有较好的效果,因而逐渐被广泛地应用于发现蛋白质生物标志物的研究中。文中主要阐述蛋白质生物标志物的发现策略以及其中特征选择与机器学习方法的原理、应用实例和适用范围,并讨论深度学习方法在本领域的应用前景及局限性,以期为相关研究提供参考。     

机器学习在功能性非编码区突变注释中的应用

在全基因组关联研究(genome-wide association studies,GWAS)中已鉴定到大量与疾病和复杂性状相关的突变位点,其中绝大部分位于基因组上的非编码区,通过多种方式参与到基因表达调控与表型产生的过程中。近年来,如何对这些突变进行系统地注释和鉴定研究是疾病基因组学研究领域的一大挑战。机器学习算法的快速发展为相关研究工作提供了新的契机。结合多组学的数据特征,机器学习方法能够对基因组上的非编码区突变进行大规模与高准确性注释和预测,对于揭示突变的具体致病机制以及指导下游实验验证具有重要的参考价值。本文主要针对机器学习算法在非编码区突变注释研究中的应用进展进行综述,并对当前研究的不足之处和未来的研究方向进行讨论,以期为相关的研究工作提供参考。     

机器学习在MALDI-TOF MS鉴定微生物中的应用

基质辅助激光解吸/电离飞行时间质谱(matrix-assisted laser desorption/ionization time-of-flight mass spectrometry,MALDI-TOF MS)是一种新兴的高通量技术,已广泛应用于临床微生物、食品微生物和水产微生物的快速鉴定。如何进一步提高MALDI-TOF MS在微生物鉴定中的分辨率是该技术当前面临的一大挑战。为了高效处理大量高维微生物MALDI-TOF MS数据,各种机器学习算法得到了应用。本文综述了机器学习在微生物MALDI-TOFMS鉴定中的应用。首先,本文在介绍机器学习在微生物MALDI-TOF MS分类中的工作流程后,进一步对MALDI-TOF MS的数据特征、MALDI-TOF MS数据库、数据的预处理和模型的性能评估进行了描述。然后讨论了典型的机器学习分类算法和集成学习算法的应用。简单的机器学习算法很难满足微生物MALDI-TOF MS分类的高分辨率的需求,而组合不同机器学习算法和集成学习算法可以获得更好的微生物分类性能。在MALDI-TOF MS数据的预处理方面,小波算法和遗传算法的应用最广,它们...     

From cancer big data to treatment: Artificial intelligence in cancer research

In recent years, developing the idea of “cancer big data” has emerged as a result of the significant expansion of various fields such as clinical research, genomics, proteomics and public health records. Advances in omics technologies are making a significant contribution to cancer big data in biomedicine and disease diagnosis. The increasingly availability of extensive cancer big data has set the stage for the development of multimodal artificial intelligence (AI) frameworks. These frameworks aim to analyze high-dimensional multi-omics data, extracting meaningful information that is challenging to obtain manually. Although interpretability and data quality remain critical challenges, these methods hold great promise for advancing our understanding of cancer biology and improving patient care and clinical outcomes. Here, we provide an overview of cancer big data and explore the applications of both traditional machine learning and deep learning approaches in cancer genomic and proteomic studies. We briefly discuss the challenges and potential of AI techniques in the integrated analysis of omics data, as well as the future direction of personalized treatment options in cancer.     

Application of radiomics and machine learning in head and neck cancers

With the continuous development of medical image informatics technology, more and more high-throughput quantitative data could be extracted from digital medical images, which has resulted in a new kind of omics-Radiomics. In recent years, in addition to genomics, proteomics and metabolomics, radiomic has attracted the interest of more and more researchers. Compared to other omics, radiomics can be perfectly integrated with clinical data, even with the pathology and molecular biomarker, so that the study can be closer to the clinical reality and more revealing of the tumor development. Mass data will also be generated in this process. Machine learning, due to its own characteristics, has a unique advantage in processing massive radiomic data. By analyzing mass amounts of data with strong clinical relevance, people can construct models that more accurately reflect tumor development and progression, thereby providing the possibility of personalized and sequential treatment of patients. As one of the cancer types whose treatment and diagnosis rely on imaging examination, radiomics has a very broad application prospect in head and neck cancers (HNC). Until now, there have been some notable results in HNC. In this review, we will introduce the concepts and workflow of radiomics and machine learning and their current applications in head and neck cancers, as well as the directions and applications of artificial intelligence in the treatment and diagnosis of HNC.     

基于机器学习的医学影像分析在药物研发和精准医疗方面的应用

MRI,PET,和CT等医学影像在新药研发和精准医疗中起着越来越重要的作用。影像技术可以被用来诊断疾病,评估药效,选择适应患者,或者确定用药剂量。 随着人工智能技术的发展,特别是机器学习以及深度学习技术在医学影像中的应用,使得我们可以用更短的时间,更少的放射剂量获取更高质量的影像。这些技术还可以帮助放射科医生缩短读片时间,提高诊断准确率。除此之外,机器学习技术还可以提高量化分析的可行性和精度,帮助建立影像与基因以及疾病的临床表现之间的关系。首先根据不同形态的医学影像,简单介绍他们在药物研发和精准医疗中的应用。并对机器学习在医学影像中的功能作一概括总结。最后讨论这个领域的挑战和机遇。     

基于精神影像和人工智能的抑郁症客观生物学标志物研究进展

抑郁症是当今社会上造成首要危害且病因和病理机制最为复杂的精神疾病之一,寻找抑郁症的客观生物学标志物一直是精神医学研究和临床实践的重点和难点,而结合人工智能技术的磁共振影像(magnetic resonance imaging,MRI)技术被认为是目前抑郁症等精神疾病中最有可能率先取得突破进展的客观生物学标志物.然而,当前基于精神影像学的潜在抑郁症客观生物学标志物还未得到一致结论 .本文从精神影像学和以机器学习(machine learning,ML)与深度学习(deep learning, DL)等为代表的人工智能技术相结合的角度,首次从疾病诊断、预防和治疗等三大临床实践环节对抑郁症辅助诊疗的相关研究进行归纳分析,我们发现:a.具有诊断价值的脑区主要集中在楔前叶、扣带回、顶下缘角回、脑岛、丘脑以及海马等;b.具有预防价值的脑区主要集中在楔前叶、中央后回、背外侧前额叶、眶额叶、颞中回等;c.具有预测治疗反应价值的脑区主要集中在楔前叶、扣带回、顶下缘角回、额中回、枕中回、枕下回、舌回等.未来的研究可以通过多中心协作和数据变换提高样本量,同时将多元化的非影像学数据应用于数据挖掘,这将有利于提高人工智能模型的辅助分类能力,为探寻抑郁症的精神影像学客观生物学标志物及其临床应用提供科学证据和参考依据.     

An Approach Based on Mutually Informed Neural Networks to Optimize the Generalization Capabilities of Decision Support Systems Developed for Heart Failure Prediction

Available clinical methods for heart failure (HF) diagnosis are expensive and require a high-level of experts intervention. Recently, various machine learning models have been developed for the prediction of HF where most of them have an issue of over-fitting. Over-fitting occurs when machine learning based predictive models show better performance on the training data yet demonstrate a poor performance on the testing data and the other way around. Developing a machine learning model which is able to produce generalization capabilities (such that the model exhibits better performance on both the training and the testing data sets) could overall minimize the prediction errors. Hence, such prediction models could potentially be helpful to cardiologists for the effective diagnose of HF. This paper proposes a two-stage decision support system to overcome the over-fitting issue and to optimize the generalization factor. The first stage uses a mutual information based statistical model while the second stage uses a neural network. We applied our approach to the HF subset of publicly available Cleveland heart disease database. Our experimental results show that the proposed decision support system has optimized the generalization capabilities and has reduced the mean percent error (MPE) to 8.8% which is significantly less than the recently published studies. In addition, our model exhibits a 93.33% accuracy rate which is higher than twenty eight recently developed HF risk prediction models that achieved accuracy in the range of 57.85% to 92.31%. We can hope that our decision support system will be helpful to cardiologists if deployed in clinical setup.     

临床决策支持知识库研究

目的 运用知识管理的理念和方法,探讨切合实际应用的临床决策支持知识库概念模型,使医院能够通过知识管理提升其核心竞争力。方法 收集国内外相关资料,系统化研究及分析具有人工智能的临床决策支持知识库的框架。结果 实施医院知识管理的关键就是必须建立一个动态的,并具有自我学习能力的临床决策支持知识库,该知识库不仅需要通过医院信息系统收集传统的医学知识,而且需要建立用于临床指南等的标准医学知识收集的引擎和隐性知识转化模型,并嵌入智能化工具,通过知识库的自我学习功能,保证其动态更新和智能化的临床决策支持能力。结论 医院知识库创建过程实质也是医院价值的创造过程,智能化的临床决策支持知识库开发不仅涉及知识的收集和处理, 还包括知识的表达,人工智能技术的嵌入和各种规则、条件及分类方法等的应用,有待进一步研究。     

Protein–DNA/RNA interactions: Machine intelligence tools and approaches in the era of artificial intelligence and big data

With the development of artificial intelligence (AI) technologies and the availability of large amounts of biological data, computational methods for proteomics have undergone a developmental process from traditional machine learning to deep learning. This review focuses on computational approaches and tools for the prediction of protein – DNA/RNA interactions using machine intelligence techniques. We provide an overview of the development progress of computational methods and summarize the advantages and shortcomings of these methods. We further compiled applications in tasks related to the protein – DNA/RNA interactions, and pointed out possible future application trends. Moreover, biological sequence-digitizing representation strategies used in different types of computational methods are also summarized and discussed.     

Imaging and artificial intelligence for progression of age-related macular degeneration

Age-related macular degeneration (AMD) is a leading cause of severe vision loss. With our aging population, it may affect 288 million people globally by the year 2040. AMD progresses from an early and intermediate dry form to an advanced one, which manifests as choroidal neovascularization and geographic atrophy. Conversion to AMD-related exudation is known as progression to neovascular AMD, and presence of geographic atrophy is known as progression to advanced dry AMD. AMD progression predictions could enable timely monitoring, earlier detection and treatment, improving vision outcomes. Machine learning approaches, a subset of artificial intelligence applications, applied on imaging data are showing promising results in predicting progression. Extracted biomarkers, specifically from optical coherence tomography scans, are informative in predicting progression events. The purpose of this mini review is to provide an overview about current machine learning applications in artificial intelligence for predicting AMD progression, and describe the various methods, data-input types, and imaging modalities used to identify high-risk patients. With advances in computational capabilities, artificial intelligence applications are likely to transform patient care and management in AMD. External validation studies that improve generalizability to populations and devices, as well as evaluating systems in real-world clinical settings are needed to improve the clinical translations of artificial intelligence AMD applications.     

Integrating Artificial and Human Intelligence into Tablet Production Process

We developed a new machine learning-based method in order to facilitate the manufacturing processes of pharmaceutical products, such as tablets, in accordance with the Process Analytical Technology (PAT) and Quality by Design (QbD) initiatives. Our approach combines the data, available from prior production runs, with machine learning algorithms that are assisted by a human operator with expert knowledge of the production process. The process parameters encompass those that relate to the attributes of the precursor raw materials and those that relate to the manufacturing process itself. During manufacturing, our method allows production operator to inspect the impacts of various settings of process parameters within their proven acceptable range with the purpose of choosing the most promising values in advance of the actual batch manufacture. The interaction between the human operator and the artificial intelligence system provides improved performance and quality. We successfully implemented the method on data provided by a pharmaceutical company for a particular product, a tablet, under development. We tested the accuracy of the method in comparison with some other machine learning approaches. The method is especially suitable for analyzing manufacturing processes characterized by a limited amount of data.KEY WORDS: artificial intelligence, machine learning, process analytical technology, process optimization, tablet manufacture